Sorry, there has been no deal between a BP and any OTC biotech drug company in the last decade. Look at Merck, that has full exposure to all things DCVax-L and has made numerous oncology biotech companies in the last two years passing over DCVax-L repeatedly. A BP could buy NWBO for pocket change but no takers.
Market Data 
Markets 
AI
